The effectiveness of IUDs may sometimes be overstated, and there's skepticism surrounding the motives of pharmaceutical companies in promoting certain medical products. The high cost of patented drugs compared to potentially lower-cost generics raises questions about the necessity and genuine benefits of certain medical interventions. If patents on medical devices, such as hormonal IUDs, expire similarly to those on medications, their prevalence in prescriptions could decline due to decreased financial incentives for manufacturers. This situation calls for a critical examination of both the efficacy and the commercial interests driving healthcare decisions.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode